PET imaging of patients with non-small cell lung cancer employing an EGF receptor targeting drug as tracer

BACKGROUND: We have previously developed (11)C-erlotinib as a new positron emission tomography (PET) tracer and shown that it accumulates in epidermal growth factor receptor (EGFR)-positive lung cancer xenografts in mice. Here, we present a study in patients with non-small cell lung cancer (NSCLC) i...

Descripción completa

Detalles Bibliográficos
Autores principales: Memon, A A, Weber, B, Winterdahl, M, Jakobsen, S, Meldgaard, P, Madsen, H H T, Keiding, S, Nexo, E, Sorensen, B S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2011
Materias:
Translational Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251890/
https://www.ncbi.nlm.nih.gov/pubmed/22095231
http://dx.doi.org/10.1038/bjc.2011.493

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251890/
https://www.ncbi.nlm.nih.gov/pubmed/22095231
http://dx.doi.org/10.1038/bjc.2011.493

Ejemplares similares